HEALTH● LOW1h ago · Sep 2, 2026, 12:24 PM
United Therapeutics bid to expand nebulized Tyvaso label gets FDA review
Seeking Alpha Tech · north america
United Therapeutics' request to expand the label for nebulized Tyvaso is under review by the FDA. This indicates a potential broadening of the drug's approved uses.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoNIMHANS, Karnataka prisons sign MoU to strengthen inmates’ mental healthcareThe HinduHEALTH1h agoMore than 500 children poisoned by free meals from a controversial school feeding programClarínHEALTH1h agoAvoid sugar in Nutrimix for anganwadi children: Kerala State Commission for Protection of Child RightsThe HinduHEALTH2h agoWhatever happened to ... children infected with HIV due to failures in healthcare?NPR News